Skip to main content

Table 4 Multivariable adjusted odds ratios of predictors for primary and selected secondary outcomes

From: Introduction of a penicillin allergy de-labelling program with direct oral challenge and its effects on utilization of beta-lactam antimicrobials: a multicenter retrospective parallel cohort study

 

Patients delabeled 30 days from admission

Beta-lactam use 6 months from admission (antibiotic users)

Beta-lactam use 6 months from admission (all comers)

Intervention Status

12.34 (4.12–53.35)

2.44 (1.00–6.15)

2.49 (1.29, 5.02)

Campus

4.25 (1.76–11.47)

0.89 (0.34–2.30)

1.68 (0.87–3.17)

Sex

0.99 (0.39–2.68)

1.26 (0.45–3.27)

0.85 (0.42–1.75)

Age

1.00 (0.98–1.03)

1.01 (0.98–1.04)

1.00 (0.98–1.02)

Charlson

1.03 (0.82–1.37)

1.07 (0.86–1.34)

0.99 (0.86–1.18)